Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Benekli

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|April 25, 2012
Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcomaAli Osman Kaya, Süleyman Büyükberber, Metin Ozkan, et al.
Archives of Gynecology and Obstetrics|September 28, 2010
Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breastMesut Seker, Ahmet Bilici, Basak Oven Ustaalioglu, et al.
Hepato-Gastroenterology|April 27, 2012
XELOX vs. FOLFOX4 as second line chemotherapy in advanced pancreatic cancerVeli Berk, Nuriye Ozdemir, Metin Ozkan, et al.
Medical Oncology (Northwood, London, England)|February 27, 2009
Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancerAli Osman Kaya, Suleyman Buyukberber, Mustafa Benekli, et al.
Journal of the National Medical Association|September 1, 2009
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancerUgur Coskun, Necati Alkis, Gokhan Celenkoglu, et al.
Journal of Cancer Research and Therapeutics|September 26, 2018
Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective studyHakan Kocoglu, Mustafa Karaca, Deniz Tural, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 17, 2009
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimensRamazan Yildiz, Mehmet Emin Kalender, Faysal Dane, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2020
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational studyMustafa Benekli, Mahmut Gumus, Metin Ozkan, et al.
BMJ Open|March 30, 2020
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD studyFaysal Dane, Kirhan Ozgurdal, Şuayib Yalçın, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 1, 2014
Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiencesBala Basak Oven Ustaalioglu, Olcun Umit Unal, Nedim Turan, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Asian Pacific Journal of Cancer Prevention : APJCP|April 25, 2012
Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcomaAli Osman Kaya, Süleyman Büyükberber, Metin Ozkan, et al.
Archives of Gynecology and Obstetrics|September 28, 2010
Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breastMesut Seker, Ahmet Bilici, Basak Oven Ustaalioglu, et al.
Hepato-Gastroenterology|April 27, 2012
XELOX vs. FOLFOX4 as second line chemotherapy in advanced pancreatic cancerVeli Berk, Nuriye Ozdemir, Metin Ozkan, et al.
Medical Oncology (Northwood, London, England)|February 27, 2009
Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancerAli Osman Kaya, Suleyman Buyukberber, Mustafa Benekli, et al.
Journal of the National Medical Association|September 1, 2009
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancerUgur Coskun, Necati Alkis, Gokhan Celenkoglu, et al.
Journal of Cancer Research and Therapeutics|September 26, 2018
Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective studyHakan Kocoglu, Mustafa Karaca, Deniz Tural, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 17, 2009
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimensRamazan Yildiz, Mehmet Emin Kalender, Faysal Dane, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2020
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational studyMustafa Benekli, Mahmut Gumus, Metin Ozkan, et al.
BMJ Open|March 30, 2020
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD studyFaysal Dane, Kirhan Ozgurdal, Şuayib Yalçın, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 1, 2014
Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiencesBala Basak Oven Ustaalioglu, Olcun Umit Unal, Nedim Turan, et al.
Pageof 13